DAIC

APRIL 6, 2024

The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST-elevation myocardial infarction (STEMI), the most severe form of a heart attack, at the American College of Cardiology’s Annual Scientific Session (ACC.24), 24), being held April 6-8 in Atltanta, GA.

Heart Attack 52

Heart Attack Heart attacks Risk Factors Research 52

Journal of the American Heart Association

FEBRUARY 28, 2024

We assessed the association of cannabis use (number of days of cannabis use in the past 30 days) with self‐reported cardiovascular outcomes (coronary heart disease, myocardial infarction, stroke, and a composite measure of all 3) in multivariable regression models, adjusting for tobacco use and other characteristics in adults 18 to 74 years old.

Myocardial Infarction 76

Myocardial Infarction Outcomes Heart Disease Stroke 76

Journal of the American Heart Association

JANUARY 10, 2025

The primary outcome was risk of an ASCVD hospitalization composite outcome (myocardial infarction, coronary artery bypass graft, percutaneous coronary intervention, stroke, transient ischemic accident) after COPD hospitalization relative to before COPD hospitalization.

Coronary Artery Bypass Graft 45

Coronary Artery Bypass Graft Cardiovascular Disease Hospital Pulmonary 45

Open Heart

OCTOBER 17, 2022

Objective Lipoprotein(a) (Lp(a)) is an important genetically determined risk factor for atherosclerotic vascular disease (ASCVD). With the development of Lp(a)-lowering therapies, this study sought to characterise patterns of Lp(a) levels in a global ASCVD population and identify racial, ethnic, regional and gender differences.

Cardiovascular Disease 52

Cardiovascular Disease Peripheral Arterial Disease Myocardial Infarction Cholesterol 52

DAIC

FEBRUARY 29, 2024

Clinical and Investigative Horizons (Session 410) Sunday, April 7 4:30 – 5:45 p.m.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Circulation

NOVEMBER 11, 2024

Introduction:Inflammation is pivotal in initiating and accelerating atherosclerotic cardiovascular disease (ASCVD). CIC features are associated with ASCVD endpoints and mortality even after adjustment for traditional risk factors and laboratory values, including hs-CRP.

Circulation 40

Circulation Cardiovascular Disease Laboratory Myocardial Infarction 40

Circulation

NOVEMBER 11, 2024

The primary outcome was a composite of the incidence of myocardial infarction and ischemic and hemorrhagic stroke, obtained by tracking the medical use data of the first-ever ICD-10 codes. HTN elevated the incidence risk of major cardiovascular disease by 2.16 years and median follow-up duration was 15.9

Myocardial Infarction 40

Myocardial Infarction Hypertension Cardiovascular Disease Outcomes 40

DAIC

APRIL 7, 2024

Brian Bergman, MD “Treatments to reduce high triglycerides are an unmet clinical need,” said Brian Bergmark, MD , of the Thrombolysis in Myocardial Infarction (TIMI) Study Group at Brigham and Women’s Hospital and Harvard Medical School and the study’s principal investigator. and Canada.

Cholesterol 116

Cholesterol Heart Attack Heart attacks Myocardial Infarction 116

Dr. Paddy Barrett

AUGUST 30, 2024

As we get older, the risk of dementia increases for everyone, regardless of risk factor control. Poor Sleep Is A Major Risk Factor For Insulin Resistance. Insulin resistance is a significant driver of cardiovascular risk. Obesity is also a key driver of risk for cardiovascular disease.

Heart Disease 111

Heart Disease Dementia Obesity Heart Attack 111

Coronary Artery Disease Journal

DECEMBER 1, 2024

Background Lipoprotein(a) [Lp(a)] is an independent risk factor for cardiovascular disease due to its unique apo(a) component and its association with atherosclerosis and thrombogenesis. In terms of safety, there was no increased risk of adverse reactions other than injection site reactions.

Heart Disease 40

Heart Disease Cholesterol Myocardial Infarction Atherosclerosis 40

Stroke Journal

NOVEMBER 9, 2023

The identification of a variant in theHDAC9gene as a risk factor for large-artery atherosclerotic stroke, and subsequently coronary artery disease, has opened novel treatment pathways for stroke and more widely atherosclerotic disease. Stroke, Volume 54, Issue 12 , Page 3182-3189, December 1, 2023.

Stroke 40

Stroke Strokes Atherosclerosis Coronary Artery Disease 40

Dr. Smith's ECG Blog

NOVEMBER 15, 2023

6.9), 3 with comparative studies consistently demonstrating a better prognosis than for those who experience AMI associated with obstructive coronary artery disease. See "Prevention of cardiovascular disease events in those with established disease (secondary prevention) or at very high risk".) Lindahl et al.

Coronary Angiogram 109

Coronary Angiogram Plaque Thrombosis STEMI 109

Open Heart

APRIL 6, 2023

Objective American Indians and Alaska Natives (AI/ANs) are an understudied population at high risk for cardiovascular diseases (CVDs); little is known about contextual factors contributing to CVDs in AI/ANs. Individual LS7 factors were summarised as ideal and poor levels. Healthcare access measures represented SDH.

Myocardial Infarction 40

Myocardial Infarction Diabetes Hypertension Outcomes 40

Dr. Malcolm Kendrick

AUGUST 26, 2022

26th August 2022 And so, after a great deal of faffing about, my article on cardiovascular disease ‘Assessing cardiovascular disease: looking beyond cholesterol’ has been made free to view. Eric Westman is a staunch ally in the crusade to look at different causal models of cardiovascular disease.

Cardiovascular Disease 40

Cardiovascular Disease Cholesterol Article Plaque 40

Circulation

NOVEMBER 11, 2024

Background:The Trial to Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide in Subjects with Type 2 Diabetes (SUSTAIN-6) trial showed cardiovascular disease (CVD) benefits of semaglutide therapy in patients with type 2 diabetes mellitus (T2DM).Purpose:To year follow-up time).Results:Among

Diabetes 40

Diabetes Blood Pressure Myocardial Infarction Kidney Disease 40

Open Heart

MARCH 1, 2024

Introduction Hypertension is the leading modifiable risk factor for cardiovascular disease and is implicated in half of all strokes and myocardial infarctions.

Blood Pressure 40

Blood Pressure Education Hypertension Quality of Life 40

Stroke Journal

FEBRUARY 1, 2024

Background:Adherence to the American Heart Association's Life’s Essential 8 (LE8) reduces the risk of cardiovascular disease. While the epsilon (ε) 4 variants within theAPOEgene have been extensively investigated as a risk factor for dementia and stroke,APOEε4 carriers have not been thoroughly studied as an at-risk population.

Myocardial Infarction 40

Myocardial Infarction Blood Pressure Dementia Diet 40

DAIC

MARCH 31, 2025

mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heart disease, said Matthew J.

Cardiovascular Disease 52

Cardiovascular Disease Plaque Coronary Artery Disease Heart attacks 52

Cardiometabolic Health Congress

JANUARY 15, 2025

Atherosclerosisa key driver of cardiovascular disease (CVD)continues to be a significant global health issue. This imbalance is partly due to limited healthcare access, fewer preventive resources, and challenges in addressing risk factors such as obesity and diabetes.

Atherosclerosis 59

Atherosclerosis Plaque Myocardial Infarction Risk Factors 59

Cardiometabolic Health Congress

FEBRUARY 1, 2024

Other studies have also unearthed more intricate connections which suggests that physiological conditions, underpinned by biological and chemical factors, may also play a pivotal role in influencing cardiovascular disease (CVD). In 2021 alone, CVD accounted for over 900,000 deaths in the U.S. and approximately 19.91

Cardiovascular Disease 105

Cardiovascular Disease Coronary Artery Bypass Graft Heart Disease Risk Factors 105

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart attacks Heart Attack Coronary Artery Disease 111

DAIC

MARCH 31, 2025

mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. mg)has potential to directly reduce inflammation, which plays a substantial role in the formation and progression of atherosclerotic plaque leading to heart disease, said Matthew J.

Cardiovascular Disease 52

Cardiovascular Disease Plaque Coronary Artery Disease Heart attacks 52

Dr. Paddy Barrett

APRIL 5, 2024

Primordial prevention is changing the environment around you so you do not develop the risk factors for heart disease and, by extension, do not get the disease early in life. Blood Pressure Control High blood pressure is the risk factor associated with the greatest number of deaths worldwide. N Engl J Med.

Heart Disease 119

Heart Disease Coronary Artery Disease Heart Attack Heart attacks 119

DAIC

JULY 18, 2024

The lead investigators for the study are Dr. Carlo De Cecco (Emory University, Atlanta) and Dr. Kolossváry added, “The PRE-VUE registry will empower us to see the true additive value of CT-derived, histologically validated plaque volumes in predicting future adverse cardiovascular events.” 2017 23, April 2020; Available from: [link].

Plaque 105

Plaque Heart Attack Heart attacks Cardiovascular Disease 105

Circulation

NOVEMBER 11, 2024

The primary endpoint was composite (cardiovascular death, myocardial infarction, stroke), and the secondary endpoints were myocardial infarction and stroke. The composite endpoint was 159 cases, myocardial infarction in 27 cases and cerebral infarction in 72 cases.

Risk Factors 40

Risk Factors Myocardial Infarction Cardiovascular Disease Stroke 40

Frontiers in Cardiovascular Medicine

DECEMBER 9, 2024

BackgroundThe peak incidence of cardiovascular diseases (CVD) usually occurs in the morning. A similar bimodal circadian rhythm pattern was observed in subgroups of patients with STEMI defined with respect to day of the week, age, sex, and coronary risk factors.

Myocardial Infarction 52

Myocardial Infarction STEMI Risk Factors Cardiovascular Disease 52

Journal of the American Heart Association

JANUARY 31, 2024

BackgroundEffective therapies for reducing cardiovascular disease (CVD) risk in people with elevated lipoprotein(a) are lacking, especially for primary prevention. Due to potential confounding by indication, we matched aspirin users to nonusers using a propensity score based on CVD risk factors. versus 55.3%,P=0.02),

Atherosclerosis 75

Atherosclerosis Risk Factors Myocardial Infarction Cardiovascular Disease 75

Dr. Paddy Barrett

MAY 17, 2024

But What About Stress & Heart Disease? When stress is included in the risk factor profile for a future heart attack, it comes in third on the list after abnormal cholesterol and smoking 1. 5 Effects of stress on the development and progression of cardiovascular disease. Bring back the real emergencies, I say!

Heart Disease 104

Heart Disease Heart attacks Heart Attack Risk Factors 104

Circulation

JANUARY 29, 2024

BACKGROUND:Up to 50% of women report sleep problems in midlife, and cardiovascular disease (CVD) is the leading cause of death in women. How chronic poor sleep exposure over decades of midlife is related to CVD risk in women is poorly understood. Circulation, Ahead of Print.

Cardiovascular Disease 51

Cardiovascular Disease Myocardial Infarction Heart Failure Education 51

Circulation

NOVEMBER 14, 2024

BACKGROUND:Many studies have explored whether individual plasma protein biomarkers improve cardiovascular disease risk prediction. We sought to investigate the use of a plasma proteomics-based approach in predicting different cardiovascular outcomes.METHODS:Among 51 859 UK Biobank participants (mean age, 56.7

Cardiovascular Disease 40

Cardiovascular Disease Dementia Biomarkers Myocardial Infarction 40

DAIC

JANUARY 25, 2024

Specifically, LODOCO reduces cardiac event risk in adult patients with established atherosclerotic cardiovascular disease (ASCVD) by an additional 31% as compared to placebo. Caristo’s CaRi-Heart technology applies advanced AI algorithms to routine cardiac CT scans to visualize and quantify coronary inflammation.

Heart Attack 110

Heart Attack Heart attacks Technology Cardiovascular Disease 110

Frontiers in Cardiovascular Medicine

FEBRUARY 27, 2024

Introduction Atherosclerotic cardiovascular disease (ASCVD) is one of the main causes of morbidity and mortality in developed countries and entails high resources use and costs for health systems. The resources use within two years of the diagnosis was estimated in order to estimate the average cost of patient follow-up.

Cardiovascular Disease 45

Cardiovascular Disease Peripheral Arterial Disease Drug Costs Myocardial Infarction 45

Cardiometabolic Health Congress

APRIL 12, 2024

Introduction: Addressing the Need for Improved LDL Management in the US There is a clear need for innovative treatments to combat cardiovascular disease (CVD). Heart disease remains the leading cause of death for men and women. However, every 40 seconds, an individual in the US suffers a heart attack.

Myocardial Infarction 64

Myocardial Infarction Cardiovascular Disease Heart Attack Heart attacks 64

Cardiometabolic Health Congress

JUNE 20, 2024

This has major potential to refine risk stratification and enhance patient management. Dr. Pradeep Natarajan (United States of America) suggested that polygenic risk scores could play a larger role in identifying individuals at risk for cardiovascular disease (CVD). Dr. Jeanine E.

Atherosclerosis 59

Atherosclerosis Cardiovascular Disease Coronary Artery Disease Myocardial Infarction 59

European Journal of Heart Failure

FEBRUARY 12, 2024

Left ventricular (LV) global longitudinal strain (GLS) assessed via feature tracking cardiac magnetic resonance imaging is associated with increased risk of major adverse cardiovascular events (MACE). LV GLS is associated with MACE in adults without prevalent cardiovascular disease (CVD). 2.38, p  = 0.04).

Cardiovascular Disease 40

Cardiovascular Disease Biomarkers Myocardial Infarction Heart Failure 40

DAIC

MAY 29, 2024

More than 70% of patients with atherosclerotic cardiovascular disease (ASCVD) are still not achieving their LDL-C target, so there remains a vast unmet need among high-risk patients for more varied and effective treatment options. Despite current treatment options, the global burden of dyslipidaemia is on the rise. JAMA Cardiol.

Cholesterol 52

Cholesterol Cardiovascular Disease Atherosclerosis Myocardial Infarction 52

All About Cardiovascular System and Disorders

MAY 23, 2024

Recommendation from UK National Institute for Health and Care Excellence is that people with or at high risk of cardiovascular disease consume at least one portion of oily fish a week. The authors reported that the regular use of fish oil supplements might be a risk factor for atrial fibrillation among general population.

Atrial Fibrillation 52

Atrial Fibrillation Stroke Strokes Cardiovascular Disease 52